Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 23c

August 5, 2021 5:07 PM EDT

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q2 EPS of ($0.37), $0.23 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $6.6 thousand versus the consensus estimate of $40 thousand.

Aurinia continues to make progress toward transforming the treatment of lupus nephritis (LN) by improving access to treatment... More